Orgenesis Inc. announced that it has entered into a securities purchase agreement to issue 1,410,256 shares at a price of $0.78 per unit and warrants at a price of $1.1 million on November 8, 2023. The warrants will be exercisable immediately following the date of issuance and may be exercised for a period of five years from the initial exercisability date at an exercise price of $0.78 per share. The transaction is expected to close on November 9, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6 USD | -5.36% |
|
-1.64% | +19.83% |
05-20 | Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020. | CI |
05-20 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+19.83% | 28.33M | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. announced that it expects to receive $1.1 million in funding